EUVIMEDEUVIMED entdecken
Crossref

TREM2-Targeting peptide tracer for neuroinflammation PET imaging

Xiaoyu Zhang, Wenhao Liu, Na Guo, Xinyan Gao, Suyun Pu, Yabin Yang, Xiaochuan Zha, Kezhi Ding, Dai Shi, Jian Zhao, Dengfeng Cheng, Zonghua Luo iD

European Journal of Nuclear Medicine and Molecular Imaging · 2026-08 · 53 (10) · 5675-5689

DOI: 10.1007/s00259-026-07929-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 26.05.2026. Verfasst von Xiaoyu Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai, 201210, China. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Membrane Glycoproteins, Receptors, Immunologic, Peptides. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Faculty Start-up Foundation of ShanghaiTech University, Shanghai Key Laboratory of Molecular Imaging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Triggering receptor expressed on myeloid cells 2 (TREM2) has emerged as an important target in neurodegenerative diseases. However, noninvasive visualization of TREM2 expression in the central nervous system (CNS) remains challenging. This study aimed to develop and evaluate a novel peptide-based positron emission tomography (PET) tracer for imaging TREM2 in CNS. METHODS: A TREM2-targeting peptide was conjugated with DOTA and radiolabeled with gallium-68 to generate [68Ga]Ga-STZL730. Binding affinity, tracer stability, lipophilicity, and cellular uptake were evaluated. Dynamic PET imaging and blocking studies were performed in wild-type mice, TREM2 knockout mice, lipopolysaccharide (LPS)-induced neuroinflammation mice, and APP/PS1 Alzheimer's disease (AD) model mice. Autoradiography and immunofluorescence staining were conducted to validate tracer specificity and target expression. RESULTS: [68Ga]Ga-STZL730 was synthesized with high radiochemical purity (> 99%) and demonstrated excellent stability in vitro. The tracer exhibited specific binding to TREM2 with an affinity (KD) of 274 nM. In vivo PET imaging demonstrated that [68Ga]Ga-STZL730 could cross the blood-brain barrier, displaying moderate and sustained brain uptake. Notably, at 20-35 min post-injection, compared to wild-type controls, brain uptake was significantly reduced in TREM2 knockout mice (41.6% lower), whereas it was markedly increased in both LPS-treated mice (113.8% higher) and AD mice (86.0% higher). Blocking studies in AD mice demonstrated the specific binding of [68Ga]Ga-STZL730. In vitro autoradiography and immunohistochemical analyses further confirmed that elevated PET signals corresponded to increased TREM2 expression, which was spatially localized to activated microglia in APP/PS1 mice brain sections. CONCLUSION: [68Ga]Ga-STZL730 is a novel peptide-based PET tracer that enables specific, noninvasive imaging of TREM2 expression in the CNS. It provides a promising tool for investigating neuroinflammation and TREM2-associated pathology in neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyMembrane GlycoproteinsReceptors, ImmunologicPeptidesNeuroinflammatory DiseasesAnimalsMiceGallium RadioisotopesTissue DistributionRadioactive TracersMaleMice, KnockoutHumansBrain

Stichwörter der Autor:innen

NeuroinflammationPeptide TracerPositron Emission TomographyTREM2

Substanzen

Membrane GlycoproteinsReceptors, ImmunologicTrem2 protein, mousePeptidesGallium RadioisotopesRadioactive TracersGallium-68

Autor:innen und Institutionen

  • School of Biomedical Engineering & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai, 201210, China.
  • School of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
  • Shanghai Institute for Advanced Immunochemical Studies & School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
  • Shanghai Clinical Research and Trial Center, Shanghai, 201210, China.
  • School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
  • Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

ORCID-Profile: Zonghua Luo

Förderung

  • Faculty Start-up Foundation of ShanghaiTech University
  • Shanghai Key Laboratory of Molecular Imaging

Zitieren

APA

Zhang, X., Liu, W., Guo, N., Gao, X., Pu, S., Yang, Y., Zha, X., Ding, K., Shi, D., Zhao, J., Cheng, D., & Luo, Z. (2026). TREM2-Targeting peptide tracer for neuroinflammation PET imaging. European Journal of Nuclear Medicine and Molecular Imaging, 53(10), 5675-5689. https://doi.org/10.1007/s00259-026-07929-9

Vancouver

Zhang X, Liu W, Guo N, Gao X, Pu S, Yang Y, et al. TREM2-Targeting peptide tracer for neuroinflammation PET imaging. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(10):5675-5689. doi:10.1007/s00259-026-07929-9

BibTeX
@article{Zhang2026,
  author = {Zhang, Xiaoyu and Liu, Wenhao and Guo, Na and Gao, Xinyan and Pu, Suyun and Yang, Yabin and Zha, Xiaochuan and Ding, Kezhi and Shi, Dai and Zhao, Jian and Cheng, Dengfeng and Luo, Zonghua},
  title = {TREM2-Targeting peptide tracer for neuroinflammation PET imaging},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {53},
  number = {10},
  pages = {5675--5689},
  doi = {10.1007/s00259-026-07929-9}
}
Kostenlos starten →